Search Results

There are 2908259 results for: content related to: Editors' pick 2011

  1. Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1323–1338, Dr Sujata Vaidyanathan, Dr Gian Camenisch, Dr Helmut Schuetz, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noelle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008323258

  2. You have free access to this content
    Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 470–481, Azhar Rashikh, Shibli Jameel Ahmad, Krishna Kolappa Pillai and Abul Kalam Najmi

    Article first published online : 7 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01414.x

  3. Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 2, February 2009, Pages: 193–212, Cynthia A. Sanoski

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.2.193

  4. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 9, September 2011, Pages: 623–631, Duncan J Campbell, Yuan Zhang, Darren J Kelly, Richard E Gilbert, Davis J McCarthy, Wei Shi and Gordon K Smyth

    Article first published online : 26 AUG 2011, DOI: 10.1111/j.1440-1681.2011.05572.x

  5. You have free access to this content
    Aliskiren in the Treatment of Hypertension and Organ Damage

    Cardiovascular Therapeutics

    Volume 29, Issue 1, February 2011, Pages: 77–87, Graziano Riccioni

    Article first published online : 25 NOV 2010, DOI: 10.1111/j.1755-5922.2010.00230.x

  6. Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 645–655, Dr Jing-He Yan, Dr Venkateswar Jarugula, Dr Ron Sabo, Dr Cheraz Cherif Papst, Dr Jack Zhang and Dr William P. Dole

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011405499

  7. Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 50, Issue 12, December 2010, Pages: 1358–1366, Dr Venkateswar Jarugula, Dr Ching-Ming Yeh, Dr Dan Howard, Dr Christopher Bush, Dr Deborah L. Keefe and Dr William P. Dole

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009359525

  8. Effects of Aliskiren, a Direct Renin Inhibitor, on Cardiac Repolarization and Conduction in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 799–811, Dr Surya Ayalasomayajula, Dr Ching-Ming Yeh, Dr Sujata Vaidyanathan, Mr Brian Flannery, Dr Hans Armin Dieterich, Dr Dan Howard, Dr Martin P. Bedigian and Dr William P. Dole

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008319330

  9. Aliskiren reduces portal pressure in portal hypertensive rats

    European Journal of Clinical Investigation

    Volume 42, Issue 5, May 2012, Pages: 526–533, Ching-Chih Chang, Wen-Shin Lee, Hui-Chun Huang, Fa-Yauh Lee, Sun-Sang Wang, Han-Chieh Lin, Jing-Yi Nong and Shou-Dong Lee

    Article first published online : 24 OCT 2011, DOI: 10.1111/j.1365-2362.2011.02611.x

  10. Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1901–1911, Dr Giuseppe Villa, Ms Stephanie Le Breton, Mr Ghionul Ibram and Mr Deborah L. Keefe

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011426432

  11. Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 359–367, Tuija Tapaninen, Janne T. Backman, Kaisa J. Kurkinen, Pertti J. Neuvonen and Mikko Niemi

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010365885

  12. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

    International Journal of Clinical Practice

    Volume 60, Issue 11, November 2006, Pages: 1343–1356, S. VAIDYANATHAN, J. VALENCIA, C. KEMP, C. ZHAO, C-M. YEH, M-N. BIZOT, J. DENOUEL, H. A. DIETERICH and W. P. DOLE

    Article first published online : 11 OCT 2006, DOI: 10.1111/j.1742-1241.2006.01164.x

  13. Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 218–228, Sam Rebello, Selene Leon, Sam Hariry, Marion Dahlke and Venkateswar Jarugula

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010365717

  14. Effect of Cyclosporine on the Pharmacokinetics of Aliskiren in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1549–1560, Dr Sam Rebello, Dr Séverine Compain, Dr Aimin Feng, Mr Sam Hariry, Dr Hans-Armin Dieterich and Dr Venkateswar Jarugula

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010385934

  15. You have free access to this content
    Effects of Renin-Angiotensin-Aldosterone System Blockade on Chlorhexidine Gluconate-Induced Sclerosing Encapsulated Peritonitis in Rats

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 1, February 2012, Pages: 75–80, Gülay Koçak, Alper Azak, Hesna Müzeyyen Astarcı, Bülent Huddam, Gökhan Karaca, Mevlüt Çeri, Murat Can, Mehmet Sert and Murat Duranay

    Article first published online : 17 JAN 2012, DOI: 10.1111/j.1744-9987.2011.01031.x

  16. You have free access to this content
    Pharmacokinetic Interaction of the Direct Renin Inhibitor Aliskiren with Furosemide and Extended-Release Isosorbide-5-Mononitrate in Healthy Subjects

    Cardiovascular Therapeutics

    Volume 26, Issue 4, Winter 2008, Pages: 238–246, Sujata Vaidyanathan, Michael Bartlett, Hans Armin Dieterich, Ching-Ming Yeh, Ana Antunes, Dan Howard and William P. Dole

    Article first published online : 11 NOV 2008, DOI: 10.1111/j.1755-5922.2008.00058.x

  17. Pharmacokinetics, Safety, and Tolerability of the Novel Oral Direct Renin Inhibitor Aliskiren in Elderly Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 4, April 2007, Pages: 453–460, Dr Sujata Vaidyanathan, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noëlle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006297921

  18. Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site

    Molecular Informatics

    Volume 30, Issue 11-12, December 2011, Pages: 973–985, Aggeliki Politi , Georgios Leonis, Haralambos Tzoupis , Dimitrios Ntountaniotis, Manthos G. Papadopoulos, Simona Golic Grdadolnik  and Thomas Mavromoustakos 

    Article first published online : 1 DEC 2011, DOI: 10.1002/minf.201100077

  19. You have free access to this content
    Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren

    British Journal of Clinical Pharmacology

    Volume 71, Issue 5, May 2011, Pages: 718–726, Tuija Tapaninen, Pertti J. Neuvonen and Mikko Niemi

    Article first published online : 11 APR 2011, DOI: 10.1111/j.1365-2125.2010.03898.x

  20. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 6, June 2012, Pages: 862–871, Rania A. Elrashidy, Mervat E. Asker and Hoda E. Mohamed

    Article first published online : 29 MAR 2012, DOI: 10.1111/j.2042-7158.2012.01508.x